✦ LIBER ✦

Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens

✍ Scribed by Thomas P. Lodise; Sandra Preston; Vijay Bhargava; Andre Bryskier; Roomi Nusrat; Sonny Chapel; Manichan Rangaraju; George L. Drusano

Book ID: 116407745
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 276 KB
Volume: 52
Category: Article
ISSN: 0732-8893
DOI: 10.1016/j.diagmicrobio.2004.12.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic Analysis of the Microbio

Pharmacodynamic Analysis of the Microbiological Efficacy of Telithromycin in Patients with Community-Acquired Pneumonia

✍ Jun Shi, Marc Pfister, Stephen G. Jenkins, Sunny Chapel, Jeffrey S. Barrett, Rue 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 200 KB

Efficacy of 750-mg, 5-day levofloxacin i

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

✍ Dunbar, Lala M.; Khashab, Mohammed M.; Kahn, James B.; Zadeikis, Neringa; Xiang, 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 347 KB

Pharmacodynamic target attainment potent

Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae

✍ Ayman M. Noreddin; Walid F. El-Khatib; Jason Aolie; Ahmed H. Salem; George G. Zh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Single daily dose of cefodizime in patie

Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized study

✍ Mario Del Palma; Danilo Rocchi; Giorgio Canepa; Angela Peri; Valeria Cantone 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Efficacy of a new pharmacokinetically en

Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains

✍ Thomas M. File; Javier Garau; Michael R. Jacobs; Brian Wynne; Monique Twynholm; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Pharmacodynamic target attainment analys

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)

✍ Ayman M. Noreddin; Theodore K. Marras; Kevin Sanders; Charles K.N. Chan; Daryl J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 86 KB